Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Zydus Lifesciences Ltd

Pharmaceuticals & Biotechnology | Large Cap

Zydus Lifesciences Ltd Health Insights
Health Score : 7.60Health Score : 7.60

Zydus Lifesciences demonstrates a strong financial standing, particularly excelling in solvency, growth, coverage, and profitability. The company efficiently manages its debt and showcases substantial growth in revenue, operating profit, and earnings per share. Strong coverage ratios indicate a robust ability to meet interest and dividend obligations. Excellent profitability metrics, including high returns on capital, equity, and assets, further underscore the company's financial health. However, there are areas needing attention, notably in liquidity and efficiency. While the company maintains a reasonable liquidity position, it is not exceptionally strong. Efficiency ratios reveal challenges in asset utilization, especially concerning fixed assets, inventory, and receivables. Capital expenditure is also relatively high, which could impact short-term cash flow. Despite these challenges, Zydus Lifesciences' strong performance in key areas suggests a positive outlook, driven by growth and profitability.

Latest Report

View All
Q2 FY26 Post Results Earnings Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Zydus Lifesciences Ltd Health Insights
Health Score : 7.60Health Score : 7.60

Zydus Lifesciences demonstrates a strong financial standing, particularly excelling in solvency, growth, coverage, and profitability. The company efficiently manages its debt and showcases substantial growth in revenue, operating profit, and earnings per share. Strong coverage ratios indicate a robust ability to meet interest and dividend obligations. Excellent profitability metrics, including high returns on capital, equity, and assets, further underscore the company's financial health. However, there are areas needing attention, notably in liquidity and efficiency. While the company maintains a reasonable liquidity position, it is not exceptionally strong. Efficiency ratios reveal challenges in asset utilization, especially concerning fixed assets, inventory, and receivables. Capital expenditure is also relatively high, which could impact short-term cash flow. Despite these challenges, Zydus Lifesciences' strong performance in key areas suggests a positive outlook, driven by growth and profitability.

Latest Report

View All
Q2 FY26 Post Results Earnings Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

30.27

Undervalued

Industry Median

28.62

Undervalued
Undervalued

Large Cap Median

30.25

Undervalued

P/E RATIO

21.38

P/B RATIO

3.98

Overvalued

Industry Median

3.17

Overvalued
Undervalued

Large Cap Median

5.04

Undervalued

P/S RATIO

3.96

Neutral

Industry Median

3.42

Neutral
Undervalued

Large Cap Median

5.48

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

12.99

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1070.8 as on Jun 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Concall Report6th Nov 25

Q2 FY26 Post Results Earnings Call

NEUTRAL SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company demonstrates robust growth across key metrics. The revenue growth rate is impressive, indicating strong market demand and effective sales strategies. The operating profit growth rate is also substantial, showing improved operational efficiency and cost management. The earnings per share (EPS) growth is exceptional, reflecting increased profitability and shareholder value. The asset growth rate indicates that the company is expanding its asset base. The net income growth rate is also significant, confirming overall financial health. The weighted average calculation further reinforces this positive trend, highlighting consistent and sustainable growth patterns.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate1.0812.9213.418.916.81
Operating Profit Growth Rate-0.0615.539.4831.0920.08
Earnings Per Share (EPS) Growth110.32-55.8198.0417.2311.39
Asset Growth Rate16.31-7.5212.827.2442.84
Net Income Growth Rate111.35-54.789.9117.629.65
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.00

The company's financial ratios present a mixed picture. Adjusted earnings per share (EPS) and cash EPS are strong, reflecting good profitability on a per-share basis. Book value per share is also high, indicating a substantial net asset value for each share. Dividend per share is reasonable, providing returns to shareholders. However, capital expenditures are relatively high, which could impact short-term cash flow. While the company demonstrates solid earnings and asset value, managing capital expenditures efficiently is crucial for maintaining financial stability.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
GoodDividend Per Share (DPS)Good
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)45.3626.2640.4748.9355.45
Cash Earnings Per Share (Cash EPS)52.2627.8746.955.3464.67
Book Value Per Share166.66173.43196.34237.16268.44
Dividend Per Share (DPS)2.6363.0710.791
Capital Expenditures (CapEx)105599288316622647
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company exhibits excellent profitability. The gross profit margin indicates efficient cost management. The return on capital employed (ROCE), return on equity (ROE), and return on assets (ROA) are all high, reflecting effective utilization of capital and assets. The operating margin and net margin further confirm strong profitability. This high profitability provides financial strength and flexibility. This enables the company to reinvest in growth opportunities and provide returns to shareholders. The weighted average calculation further supports this assessment, highlighting consistent and sustainable profitability patterns.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin17.2218.223.6426.4326.03
Return on Capital Employed (ROCE)1315222421
Return on Equity (ROE)27.1711.9420.0419.5118.9
Return on Assets (ROA)12.0915.118.6719.2416.17
Operating Margin21.8922.3927.5430.3731.22
Net Margin30.2512.1420.3320.1118.87
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

The efficiency ratios indicate areas where the company faces challenges in asset utilization. The fixed asset turnover ratio is low, suggesting that the company is not generating enough revenue from its fixed assets. The inventory turnover ratio indicates that the company may have obsolete or slow-moving inventory. The receivables turnover ratio suggests that the company takes longer to collect payments from its customers. The days sales in inventory and receivable days further confirm these inefficiencies. The capital turnover ratio is also low, indicating that the company is not efficiently using its capital to generate revenue. Addressing these inefficiencies can improve the company's overall financial performance.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.251.51.581.771.02
Inventory Turnover Ratio3.633.954.364.634.2
Receivables Turnover Ratio4.724.444.065.035.75
Days Sales in Inventory Ratio100.5592.4183.7278.8386.9
Receivable Days77.3382.2189.972.5663.48
Capital Turnover Ratio0.880.980.980.970.88
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company's coverage ratios are exceptionally strong. The interest coverage ratio indicates a robust ability to meet interest obligations, reflecting sound financial management. The equity dividend coverage ratio is also high, demonstrating a strong capacity to cover dividend payments to shareholders. These high coverage ratios provide financial stability and flexibility. This enables the company to manage its debt and dividend obligations effectively. The weighted average calculation further supports this assessment, highlighting consistent and conservative coverage practices.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio41.0320.8860.6537.3116.08
Equity Dividend Coverage Ratio16.673.2312.54.1750
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits exceptional solvency. The debt ratio and debt-to-equity ratio are very low, indicating minimal reliance on debt financing. The equity ratio is nearly perfect, showing that the company is primarily financed by equity. The debt-to-asset ratio is also minimal, confirming that the company's assets are not funded by debt. This strong solvency position provides financial stability and flexibility. This enables the company to pursue growth opportunities without being burdened by excessive debt obligations. The weighted average calculation further supports this assessment, highlighting consistent and conservative debt management practices.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.020000.13
Debt to Equity Ratio0.020000.15
Equity Ratio0.981110.87
Debt To Asset Ratio0.010000.07
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 4.68

The company's liquidity position reflects a mixed performance. While the current and quick ratios suggest an ability to cover short-term liabilities, they aren't exceptionally high. The cash ratio indicates a lower proportion of cash holdings compared to current liabilities. The operating cash flow ratio, while positive, suggests reliance on operational cash for short-term obligations. On the positive side, the company has increased its current ratio in recent years. However, maintaining sufficient liquid assets to meet immediate obligations remains crucial for financial stability.

WeakCurrent RatioWeak
AverageQuick RatioAverage
WeakCash RatioWeak
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.121.411.431.140.8
Quick Ratio0.750.981.050.830.53
Cash Ratio0.110.070.120.230.07
Operating Cash Flow Ratio0.210.340.360.530.1
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 10 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Abbott India Ltd8.6835.89Neutral1892.00730.391552.00
2Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
3Alkem Laboratories Ltd8.0827.91Neutral3005.00182.762351.00
4Lupin Ltd7.8420.16Neutral8816.00139.255355.00
5Cipla Ltd7.6228.15Neutral5883.0043.523862.00
6Mankind Pharma Ltd7.6152.10Highly Overvalued3617.0049.341938.00
7Zydus Lifesciences Ltd7.6021.38Neutral8475.0035.385124.00
8Laurus Labs Ltd7.1085.84Neutral1778.0013.72890.00
9Dr Reddys Laboratories Ltd6.4925.31Neutral6454.0038.584158.00
10Glenmark Pharmaceuticals Ltd6.3645.87Neutral4572.00-7.121362.00
Management Assessment Summary
GreenStrong Management

Overall, Zydus Lifesciences demonstrates effective management, as evidenced by strong financial performance and increasing operational efficiency. The company has shown consistent sales and profit growth, coupled with a rising OPM. Prudent capital management is reflected in healthy ROCE and ROE figures. While there is a slight increase in debt, it appears to be manageable. High promoter holding indicates confidence and alignment with shareholder interests.

Category Metric Value Assessment
PROS Sales Growth (TTM) 19% Strong revenue expansion
Profit Growth (TTM) 21% Strong and sustainable profit growth
OPM (Mar 2025) 33% Improving operational efficiency
ROCE (Mar 2025) 24% Productive use of capital
CONS Borrowings (Mar 2025) ₹ 3,213 Cr. Moderate Increase in Borrowings
Other Income Contribution (Mar 2023) -₹422 Cr Profitability affected by Other Income
ExcellentFinancial Performance & GrowthExcellent
ExcellentCapital Efficiency & ReturnsExcellent
GoodFinancial Health & PrudenceGood
AverageStrategic & Operational IndicatorsAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Zydus Lifesciences indicates a moderate level of risk. The primary concern is the segment performance volatility, as evidenced by fluctuations in quarterly sales and profit growth. There is a need for proactive risk management to ensure sustained financial health.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageContingent liability evaluationAverage
AverageRegulatory compliance cost trendsAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Contingent liability evaluation

04.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101072.51Bearish
  3. SMA 201069.24Bullish
  4. SMA 501084.59Bearish
  5. EMA 101071.54Bullish
  6. EMA 201072.88Bearish
  7. EMA 501079.55Bearish
  8. DEMA 101071.34Bullish
  9. DEMA 201068.47Bullish
  10. DEMA 501073.36Bearish
  11. TEMA 101071.99Bullish
  12. TEMA 201070.71Bullish
  13. TEMA 501063.65Bullish
  14. MACD-2.80Bullish
  15. ADX21.39Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.57Neutral
  3. CCI33.86Neutral
  4. ROC 9-0.06Bearish
  5. ROC 140.87Bullish
  6. ROC 25-0.52Bearish
  7. Stoch K51.66Neutral
  8. Stoch D53.08Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1081.06Neutral
  3. BB Middle1069.24Neutral
  4. BB Lower1057.41Neutral
  5. ATR6.78Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI65.45Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101070.31Bullish
  3. SMA 201075.18Bearish
  4. SMA 501088.11Bearish
  5. EMA 101072.29Bearish
  6. EMA 201076.48Bearish
  7. EMA 501078.73Bearish
  8. DEMA 101069.52Bullish
  9. DEMA 201068.80Bullish
  10. DEMA 501089.16Bearish
  11. TEMA 101071.86Bullish
  12. TEMA 201065.61Bullish
  13. TEMA 501072.19Bullish
  14. MACD-5.52Bullish
  15. ADX17.06Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI44.39Neutral
  3. CCI-36.83Neutral
  4. ROC 91.07Bullish
  5. ROC 14-0.16Bearish
  6. ROC 25-3.08Bearish
  7. Stoch K54.22Neutral
  8. Stoch D51.59Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1095.12Neutral
  3. BB Middle1075.18Neutral
  4. BB Lower1055.25Neutral
  5. ATR9.49Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI40.18Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101073.62Bearish
  3. SMA 201087.45Bearish
  4. SMA 501070.05Bullish
  5. EMA 101075.36Bearish
  6. EMA 201078.96Bearish
  7. EMA 501057.67Bullish
  8. DEMA 101068.30Bullish
  9. DEMA 201080.38Bearish
  10. DEMA 501106.82Bearish
  11. TEMA 101065.81Bullish
  12. TEMA 201066.32Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.47Bearish
  15. ADX19.03Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.75Neutral
  3. CCI-88.11Neutral
  4. ROC 9-1.52Bearish
  5. ROC 14-2.26Bearish
  6. ROC 25-0.19Bearish
  7. Stoch K27.75Neutral
  8. Stoch D25.72Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1119.68Neutral
  3. BB Middle1087.44Neutral
  4. BB Lower1055.21Neutral
  5. ATR15.59Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI27.54Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101087.55Bearish
  3. SMA 201082.48Bearish
  4. SMA 50999.48Bullish
  5. SMA 100948.60Bullish
  6. SMA 200954.52Bullish
  7. EMA 101079.42Bearish
  8. EMA 201067.38Bullish
  9. EMA 501017.70Bullish
  10. EMA 100979.65Bullish
  11. EMA 200960.78Bullish
  12. DEMA 101081.14Bearish
  13. DEMA 201101.12Bearish
  14. DEMA 501079.67Bearish
  15. DEMA 1001021.13Bullish
  16. DEMA 200976.98Bullish
  17. TEMA 101068.56Bullish
  18. TEMA 201092.41Bearish
  19. TEMA 501112.98Bearish
  20. TEMA 1001063.96Bullish
  21. TEMA 200990.21Bullish
  22. MACD22.22Bearish
  23. ADX43.18Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI55.72Neutral
  3. CCI-50.43Neutral
  4. ROC 14-1.87Bearish
  5. ROC 257.98Bullish
  6. Stoch K28.16Neutral
  7. Stoch D32.78Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1113.31Neutral
  3. BB Middle1082.48Neutral
  4. BB Lower1051.66Neutral
  5. ATR25.26Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI42.17Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20945.23Bullish
  3. SMA 50954.18Bullish
  4. EMA 20975.36Bullish
  5. EMA 50953.35Bullish
  6. DEMA 201016.03Bullish
  7. DEMA 50967.87Bullish
  8. TEMA 201056.93Bullish
  9. TEMA 50964.82Bullish
  10. MACD37.13Bullish
  11. ADX20.83Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI66.19Neutral
  3. CCI206.21Overbought
  4. ROC 1420.99Bullish
  5. ROC 2520.13Bullish
  6. Stoch K90.57Overbought
  7. Stoch D87.67Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1091.76Overbought
  3. BB Middle945.23Neutral
  4. BB Lower798.69Neutral
  5. ATR55.06Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI86.63Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6927.02Bullish
  3. SMA 12950.15Bullish
  4. SMA 24975.41Bullish
  5. EMA 6954.99Bullish
  6. EMA 12945.49Bullish
  7. EMA 24915.81Bullish
  8. DEMA 6975.67Bullish
  9. DEMA 12956.43Bullish
  10. DEMA 241002.16Bullish
  11. TEMA 61001.11Bullish
  12. TEMA 12946.82Bullish
  13. TEMA 24965.80Bullish
  14. MACD120.41Bearish
  15. ADX23.69Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI61.67Neutral
  3. CCI74.59Neutral
  4. ROC 2513.02Bullish
  5. ROC 50209.24Bullish
  6. Stoch K38.66Neutral
  7. Stoch D51.33Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1048.15Overbought
  3. BB Middle944.61Neutral
  4. BB Lower841.07Neutral
  5. ATR103.10High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI55.75Neutral